Vol. 276, Issue 2, H758-H765, February 1999
SPECIAL COMMUNICATION
Real-time measurement of cardiac vagal tone in conscious
dogs
C. J. L.
Little1,
P. O. O.
Julu2,
S.
Hansen2, and
S. W. J.
Reid1
1 Department of Veterinary
Clinical Studies, University of Glasgow Veterinary School, Bearsden,
Glasgow G61 1QH; and 2 Peripheral
Nerve and Autonomic Unit, Southern General Hospital, Glasgow G51 4TF,
United Kingdom
 |
ABSTRACT |
Rapid changes in heart rate are caused by
changes in parasympathetic tone. The NeuroScope is an electronic device
designed to offer an objective real-time measure of instantaneous
cardiac vagal tone by phase demodulation of a high-resolution time
domain of R-R wave intervals. Data are displayed against an arbitrary but linear scale, the cardiac index of parasympathetic activity (CIPA).
To validate this method, 10 conscious healthy dogs were each given six
incremental doses of atropine (0.01 mg/kg) to a total dose of 0.06 mg/kg or equal volumes of saline. A dose-response curve was
constructed. At the maximum dose of atropine, CIPA values fell to 1.3 ± 0.7% (SD) of baseline, whereas R-R intervals fell to 51.5 ± 11.5% of baseline, and standard deviation of the R-R wave interval
fell to 10.6 ± 6.5% of baseline. These findings show that the
NeuroScope can provide a specific real-time index of cardiac vagal tone
in dogs without need for recourse to atropine.
NeuroScope; parasympathetic tone; heart rate variability; autonomic
nervous system; atropine
 |
INTRODUCTION |
IN HEALTH, HEART RATE is determined by the intrinsic
rate of spontaneous depolarization of the sinoatrial (SA) node modified by the autonomic nervous system. Sympathetic influences accelerate heart rate, and parasympathetic discharges cause deceleration, but at
rest there is a tonic level of activity in each of these components;
heart rate depends on the interplay between these (14). The heart is
not a continuous pump; each heartbeat is a discrete event, and the R-R
wave intervals (heart periods) vary as sympathetic and parasympathetic
influences affect each beat. In humans and the dog at rest,
parasympathetic (vagal) tone predominates. Under steady-state
conditions the relationship between R-R wave interval and the frequency
of cardiac vagal stimulation is linear; an increment in the activity of
vagal efferents prolongs the R-R interval by a fixed value independent
of the initial R-R interval (32).
Cardiac vagal tone is reflexly generated through baroreceptor
stimulation (23). These baroreflexes are mainly responsible for resting
cardiac vagal tone in the conscious breathing animal, although
chemoreceptor afferents and other reflex inputs associated with
breathing, for instance, may modify vagal outflow (8, 17). Baroreflex
modulation of SA node function is strongly influenced by the timing as
well as the intensity of the stimulus (6, 10), but the usual
physiological stimulus is the rapid rise in blood pressure during the
ejection period of ventricular systole. The latency of this reflex is
constant and short compared with the length of the cardiac cycle,
averaging ~160-180 ms in dogs and 240 ms in humans (10, 22). It
follows that the effect of brief arterial baroreceptor stimulation
arrives at the SA node in the period of the cardiac cycle after the
stimulus and is synchronized to the preceding pulse as a result of the
fixed latency. Moreover, at normal heart rates, this volley of vagal
impulses arrives at the SA node at the stage of the cardiac cycle
during which it seems to be particularly sensitive to this stimulus
(10). Thus each ventricular systole causes baroreceptor stimuli that
act via cardiac vagal tone to delay the subsequent cardiac cycle or cycles (9). The delay in the cycle(s) induced by baroreceptor stimulation is proportional to the baroreceptor stimulus strength and
duration (10). Volleys of vagal nerve impulses liberate ACh from
synaptic vesicles, which is added to the ACh remaining at the SA node
at the end of the previous heart period, but the concentration of this
neurotransmitter also declines exponentially because of degradation by
acetylcholinesterase (29). In effect, the vagally mediated prolongation
of heart period is proportional to the concentration of ACh at the SA
node (22). Thus the SA node actually integrates (or adds up) the vagal
nerve impulses.
Rapid changes in heart rate are caused by changes in the level of
parasympathetic tone. Sympathetic influences affect heart rate directly
and reflexly via changes in peripheral resistance, but these controls
act slowly in comparison to cardiac vagal tone (14). Baroreceptor
control of heart rate can be modeled as a closed-loop feedback system
with a delay in the sympathetic nervous system that makes it resonate
at ~0.1 Hz (9). In a classical study of the firing rate of cardiac
vagal efferent fibers on the heart period performed in dogs, Katona and
others (22) showed that it was possible to predict the heart period
from cardiac vagal efferent activity, even while the sympathetic nerves
were intact. These authors further demonstrated that a simple
electronic model successfully described moderate changes in the heart
period caused by changes in vagal nerve activity. Therefore, it follows that it should be possible to deduce the immediate effect of
parasympathetic activity on the heart by appropriate analysis of the
pulse-synchronized variation in heart period.
The NeuroScope is a novel electronic device that has been designed to
offer an objective real-time measure of instantaneous cardiac vagal
tone on the basis of these physiological principles. Cardiac vagal tone
introduces delays in the onset of cardiac cycles (10) that can be
detected with the aid of a template similar to that of Katona and
others (22). The instrument detects pulse-synchronized delays in the
onset of successive cardiac cycles as phase shifts, quantifies these
delays in milliseconds, and converts them to measures of cardiac
parasympathetic activity. It follows from the arguments set out
previously that the NeuroScope is only of use for the evaluation CIPA
when the heart is in sinus rhythm.
Here we compare the NeuroScope technique with other conventional and
commonly used methods of measuring cardiac parasympathetic activity in
dogs given graded doses of atropine. The aim was to evaluate the
specificity of CIPA as an index of cardiac parasympathetic activity.
 |
MATERIALS AND METHODS |
Ten healthy mature male beagle dogs exhibiting sinus heart rhythm were
used in the study. All procedures were performed in fully conscious
animals between 10 AM and 4 PM after an overnight fast. Each dog had
been trained to stand in a semisupported standing position. They were
familiar with the laboratory environment and the investigators.
Adhesive silver-silver chloride electrocardiogram (ECG) electrodes were
fastened to the limbs with tape, and a 20-gauge intravenous catheter
was placed in the cephalic vein of a forelimb for drug administration.
Measurement of the CIPA.
Beat-by-beat R-R wave intervals were recorded by downloading the analog
ECG signal to the NeuroScope and using an R wave recognition template.
The detection procedure for the CIPA involves accurate sampling of the
ECG to obtain a high-resolution time domain of the R-R wave intervals.
Pulse-synchronized delays that are specifically caused by cardiac vagal
tone are obtained through phase demodulation of the time domain. A
patented system of phase locks filters out slow responses originating
from the sympathetic nervous system and other sources, thereby allowing
the pulse-synchronized parasympathetic responses to be measured (19a).
Results are displayed on a computer screen in real time against an
arbitrary but linear scale, the CIPA, which was derived from human
volunteers through atropinization according to principles set out by
Julu (18). The parasympathetic control of the heart measurable by any
index can be defined as the difference in magnitudes of that index
before and after the elimination of all vagal effects on the heart,
i.e., the response to full atropinization (18). Mean basal CIPA in a
sample of supine resting human volunteers breathing quietly was
arbitrarily set at 10 units. The units were derived by dividing the
measurable effects of cardiac vagal activity into 10 equal parts, thus
giving a linear scale with an absolute zero reference point. Zero on the CIPA scale represents no measurable parasympathetic influence on
heart rate, as observed during full atropinization. All data were
downloaded in real time to a laptop computer, where these data were
stored automatically. (Further details concerning the operation of
NeuroScope are supplied in the
APPENDIX.)
After instrumentation, each dog was allowed to rest for
2,000
heartbeats. Then, as a test of intact cardiac vagal tone, the oculocardiac reflex was induced by pressing on the closed eyelids for
20 s (13). A further rest period of
800 heartbeats was allowed
before the study continued, and the last 500 beats of this rest period
were designated baseline. Six aliquots of atropine (0.01 mg/kg iv) were
given to each dog at 10-min intervals to a cumulative dose of 0.06 mg/kg. Each injection was followed by a 1.5-ml flush of saline. Data
were collected continuously during the study and for 10 min after the
final dose. At the end of the study period, digital pressure was
applied to the eyes again to induce evidence of residual cardiac vagal
tone. On a separate occasion the same dogs were prepared and studied in
exactly the same way, but the atropine injection was replaced with a
similar volume of normal saline solution. The studies were performed in random order according to a predetermined schedule.
All data were examined visually during data collection throughout the
recording to ensure that the dogs were exhibiting a sinus rhythm. For
the purposes of data analysis, beats that were not of sinus origin were
excluded. The 50 heartbeats before each injection and the subsequent
50-100 beats were also excluded from data analysis to avoid
effects from handling of the dogs and to allow for equilibration as
observed during the continuous monitoring. For each dose aliquot in
each dog, all the remaining heartbeats were subject to further analysis.
Statistical methods.
To assess whether there was a significant difference between the
responses of the animals between the two treatments, the resting and
experimental data were analyzed using ANOVA techniques with repeated
measures. The factors were dog, treatment, and dose, where treatment
and dose were regarded as fixed effects and dog as a random effect. For
the resting data the analysis was performed on the mean CIPA values for
each segment of 250 heartbeats for each dog and for each treatment. For
the experimental data, because the heart rate changed and episodes of
second-degree heart block were sometimes observed during administration
of atropine, the analysis was performed on the mean of the CIPA values
for each animal at each dose for each treatment. The analysis of the
experimental data was also performed on normalized data, where the CIPA
values were expressed as a percentage of the baseline value at
dose 0 (i.e., the 500-beat time frame
immediately preceding the injections of atropine or saline). Finally,
ANOVA was applied to the treated (atropine) group alone, and Tukey's
pairwise comparison of means was used to identify at which dose the
CIPA values were significantly different. Significance was set at 5%
for all analyses.
 |
RESULTS |
Resting and baseline data.
All dogs exhibited sinus rhythm during the resting and baseline
recordings, and only nine nonsinus beats were identified in three dogs
during this period. The CIPA values recorded from the dogs in this
study were generally much higher than those recorded from healthy human
subjects. The mean of the mean CIPA values over 500 heartbeats for the
10 dogs at baseline, before the injection of saline and atropine, were
38.9 ± 16.8 and 43.8 ± 19.1 (SD) units, respectively. Table
1 provides a summary of these measurements for each dog at baseline before the injection of saline or atropine. During these recordings, CIPA values and R-R interval length in each
dog varied over a short time frame. In some, but not all, animals,
respiratory modulation of the R-R interval length was marked.
CIPA values generally rose as R-R interval length increased and as
variability in the R-R wave intervals rose. Over segments of 250 cardiac cycles in the resting period before injection of saline or
atropine, the average CIPA value for each dog tended to be relatively
stable and characteristic for that dog, although dog-to-dog differences
were not explored statistically. Typical examples of these resting
recordings are shown in Fig. 1, where each
example consisted of a time series of 500 heartbeats.

View larger version (31K):
[in this window]
[in a new window]

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
Time series plots illustrating beat-by-beat electrocardiographic R-R
wave intervals and cardiac index of parasympathetic activity (CIPA)
values from 2 healthy male beagle dogs [dog
1 (A) and
dog 2 (B) in Table 1] recorded at
rest in a semisupported standing position.
A: R-R wave intervals and CIPA values
vary over a short time frame at rates that do not closely correspond
with respiratory frequency. Respiratory rate = 17 breaths/min, mean R-R
wave interval = 727.8 ± 138.8 (SD) ms, mean CIPA = 35.6 ± 10.6 (SD). B: marked respiratory sinus
arrhythmia evident as a fairly regular oscillation in R-R wave
intervals and corresponding CIPA data. Breathing rate averaged 14 breaths/min, mean R-R wave interval = 768.4 ± 218 ms, mean CIPA = 40.5 ± 9.6.
|
|
Figure 2 illustrates the induction of the
oculocardiac reflex in one dog by the application of pressure to the
eyes; in all dogs, induction of this reflex was associated with
lengthening of the R-R interval and increase in R-R wave variability;
beat-by-beat CIPA values rose steeply to reach a peak within 15-20
s in all dogs.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of application of digital pressure to closed eyelids of a
healthy male beagle dog (dog 3 in
Table 1) at rest in a semisupported standing position. Oculocardiac
reflex is induced by this procedure, which leads to a marked increase
in R-R wave interval variability and slowing of heart rate. CIPA values
rose steeply. Vertical lines, period during which pressure was applied
to eyeballs.
|
|
Statistical analysis of the resting data in the 10 dogs showed no
systematic or significant differences between the measurements preceding atropine or saline injection. Moreover, systematic and statistically significant differences were also absent among the eight
consecutive 250-beat segments comprising this resting period.
Atropinization.
Administration of a series of atropine boluses to these dogs
systematically reduced the beat-by-beat CIPA values in all cases. After
a cumulative dose of 0.06 mg/kg the CIPA values had fallen to <2.3%
of the baseline value in all cases [1.3 ± 0.7% (SD), range
0.3-2.3%; Fig.
3A].
Variability of this index also fell dramatically when atropine was
administered. In the control experiments, by contrast, a series of
boluses of saline had no effect on the CIPA in these dogs (Fig.
3A). After atropinization, induction of the oculocardiac reflex by application of pressure to the eyes had
no noticeable effect on the CIPA or heart rate, thus confirming that
cardiac vagal tone had been abolished. When saline was administered in
place of atropine, this reflex remained intact.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of cumulative doses of atropine and saline on indexes of cardiac
vagal tone in conscious beagle dogs
(n = 10). All indexes were
measured concurrently and normalized as percentages of values at
baseline (dose 0).
A: mean values of CIPA among all dogs
during cumulative atropinization or repeated injections of saline.
Vertical lines, SE. B: mean values of
electrocardiogram R-R wave intervals in all dogs recorded during study
in A. Vertical lines, SE.
C: mean values of standard deviation
of R-R intervals in all dogs recorded during study in
A. Vertical lines, SE. Note abolition
of CIPA and very low variability of this index after atropinization. By
contrast, a relatively large residual value of R-R wave interval and
its standard deviation are found at maximum dose of atropine. Saline
(control) injections had no effects on any of indexes, which remained
stable throughout study. For CIPA, mean value was 107.35% of baseline
and coefficient of variation (CV) of all data was 30.35%. For R-R wave
intervals, mean value was 101.4% of baseline and CV of all data was
10.0%. For standard deviation of R-R wave interval, mean value was
110.5% and CV of all data was 27.3% of baseline.
|
|
Atropinization reduced the mean R-R wave interval in all dogs, and
after a cumulative dose of 0.06 mg/kg this value fell to a mean of 51.5 ± 11.5% (SD) of the value at baseline (range 30.3-67.3%; Fig. 3B). Standard deviation of the
R-R wave interval also fell in each of these dogs as atropinization
proceeded, but the residual value of this index was higher than the
residual CIPA in all dogs at the maximum atropine dose [10.6 ± 6.5% (SD), range 2.9-22.5%, as a percentage of the
baseline value]. These data are illustrated in Fig.
3C.
Statistical analysis of the CIPA data showed a significant
dose-treatment interaction, which confirmed the observations from Fig.
3A that the response in the treatment
groups differed at different doses. ANOVA and post hoc Tukey's
pairwise comparison of means applied to the normalized atropine group
data alone demonstrated a significant difference between
dose 1 (0.01 mg/kg) and
dose 2 (0.02 mg/kg) only.
The dose-response curves of the three different indexes of cardiac
vagal tone to atropine differ in shape. Scrutiny of Fig. 3 shows that
the dose responses of the standard deviation of the R-R wave interval
and CIPA to atropine resemble each other, but these curves differ from
the dose-response curve of the R-R wave interval. The indexes of
variability (CIPA and standard deviation of the R-R wave interval) fell
more sharply than the mean R-R interval itself, particularly in
response to the second aliquot of atropine.
Second-degree heart block was observed in all dogs at some point during
the atropine response study, usually after the second or third aliquot
of atropine had been administered intravenously (Fig.
4).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Second-degree heart block during intravenous atropinization
(dog 6 in Table 1). Consecutive R-R
wave intervals are shown while 2nd aliquot of atropine was administered
(vertical line). Second-degree heart block, peaks approximately twice
as long as predominant R-R wave intervals, occurred frequently during
this period. Longest R-R interval corresponded to 2 unconducted P waves
on electrocardiogram recording (not shown). Because NeuroScope can only
be used for evaluation of cardiac vagal tone when heart is in sinus
rhythm, all episodes of 2nd-degree heart block were excluded from our
analyses.
|
|
 |
DISCUSSION |
Atropinization of 10 conscious beagle dogs led to reduction in R-R wave
intervals, standard deviation of the R-R wave intervals, and a CIPA as
measured by a noninvasive device, the NeuroScope. In the case of CIPA,
the index was almost abolished by cumulative dosing of atropine, and
variability of this index between dogs also fell to a very low level,
indicating the high specificity of this index. The change in R-R
interval length (or heart rate) after atropinization is commonly used
as an index of cardiac vagal tone (12, 20, 33). Standard deviation or
variance of R-R wave interval length over short time periods has also
been used frequently as an index of cardiac parasympathetic activity
(1, 33, 36). Our results show that CIPA is more specific for cardiac vagal tone than either of these two indexes.
Atropine is a competitive muscarinic receptor antagonist that prevents
the action of ACh on the SA node of the heart. Physiological responses
to parasympathetic (vagal) nerve impulses are thereby attenuated or
abolished. Because the peripheral vasculature is virtually devoid of
muscarinic receptors, the effects of atropine on heart rate account for
all the important direct effects of this drug on the cardiovascular
system. In veterinary clinical use, atropine is generally used in the
dose range 0.01-0.04 mg/kg in dogs (5). However, numerous
experimental studies have been performed using this drug in conscious
and anesthetized dogs in doses ranging from 0.0003 to 1.5 mg/kg (7, 15,
21, 25, 38). These studies have established that very small doses of atropine (<0.01 mg/kg) slow the heart, possibly because of a central vagal-stimulating action, although the mechanism is controversial (19,
21, 25). In conscious dogs, vagal effects on the heart are reported to
be abolished at doses of ~0.04 mg/kg, but certain anesthetic agents
such as morphine and
-chloralose seem to enhance cardiac vagal tone.
Very high doses of atropine (>0.2 mg/kg) appear to cause excess
tachycardia, an effect that may be due to ganglionic blockade (7, 40).
In the present study, cumulative intravenous atropine injections caused
a dose-dependent reduction in the CIPA values recorded from conscious
dogs, and at the maximum dose utilized, this index was almost abolished
in all cases to a mean value of only 1.3% of the resting value. This
observation indicates that CIPA is a highly selective and dependable
index of cardiac vagal tone. In keeping with this observation, in
unmedicated dogs the CIPA values generated on a beat-by-beat basis rose
steeply when cardiac vagal tone was increased by the application of
digital pressure to the eyes, a well-established vagal maneuver. This
phenomenon was abolished by atropinization. At rest, CIPA values
recorded from these dogs varied widely over a short time scale, which
is consistent with known physiological concepts of the beat-by-beat control of the cardiovascular system (9).
As atropinization proceeded in these dogs, the mean R-R wave interval
fell. This observation was expected but was of only limited value as an
index of cardiac vagal tone, because the initial and final mean R-R
wave intervals varied quite substantially between dogs. The final value
varied from 30.3 to 67.3% of that recorded at baseline [51.5 ± 11.5% (SD)]. A dose-dependent reduction in the standard
deviation of the R-R wave interval with cumulative atropinization was
also observed in this experiment. However, at the maximum dose of
atropine this index was not completely abolished, with the mean value
recorded from the 10 dogs 10.6% of the baseline value. Moreover, very
substantial differences were observed between dogs. This observation
was to be expected, because although the main contributor to the
variability of the R-R wave interval is cardiac vagal tone, cardiac
sympathetic tone will also affect this, particularly because this index
was measured over a period of several minutes. The heterogeneity of
responses of the R-R wave intervals and its standard deviations between dogs can be explained by differences in the relative dominance of
sympathetic and parasympathetic autonomic tone between individuals, since these two indexes are not very specific for cardiac vagal tone.
Various methods for the evaluation of vagal effects on heart rate have
been described previously. Respiratory modulation of heart rate,
respiratory sinus arrhythmia (RSA), occurs by modulation of cardiac
vagal tone (8, 16, 20, 34, 39). Whether RSA is secondary to respiratory
blood pressure variability or vice versa is controversial, but because
these components are connected through a closed-feedback loop, either
variable could lead the other (2, 4, 8, 9, 28, 34). In dogs and humans
under controlled conditions, RSA has been shown to be closely correlated with parasympathetic control (11, 12, 20). On the other
hand, it has long been known that, over a range of breathing frequencies, fluctuations in heart rate are not necessarily in phase
with respiration (3, 28). RSA in cooperative human patients can be
maximized by asking them to breathe deeply at a slow rate, often with
the aid of a timing device such as a metronome. By contrast, in
conscious and freely behaving animals, rate and depth of breathing can
vary substantially from moment to moment, particularly in dogs, which
tend to pant rapidly when they are warm, stressed, or excited.
Moreover, because breathing rate and depth differ, it is difficult to
make meaningful comparisons between individuals or over a given time period.
Another approach to the issue of noninvasive assessment of cardiac
vagal tone is to study heart rate variability (HRV). This latter
approach has generated numerous publications, but interpretation of the
results vis-à-vis cardiac vagal tone is difficult. There is
agreement that high-frequency variation in heart periods is solely
associated with parasympathetic tone (2, 35). Lower-frequency HRV seems
to be associated with changes in sympathetic and parasympathetic tone
interacting with each other; additional mechanisms such as thermoregulation and the renin-angiotensin-aldosterone system have also
been implicated, particularly for rhythms with frequencies <0.1 Hz
(2, 35, 38). Evaluation of HRV to elucidate the components of autonomic
control is crucially dependent on stationary conditions (1), which are
difficult to achieve in freely behaving animal subjects. The necessity
for stationary conditions prevents the use of HRV for studies of reflex
modulation of heart rate, such as in the oculocardiac reflex or
exercise tests. It is for such dynamic autonomic states that CIPA would
appear to be most useful.
In contrast to measures of RSA and HRV as indexes of cardiac vagal
tone, the CIPA reported in this study is generated in real-time without
the active cooperation of the subject. The measurement appears to be a
specific and a sensitive indicator of beat-by-beat cardiac vagal tone
that varies appropriately in response to well-established vagal
maneuvers. Moreover, because the index is displayed in units of a
linear scale with an absolute zero reference point, comparisons of
cardiac vagal tone between individuals and over a given period of time
are greatly facilitated.
An interesting observation from the present study was that the
dose-response curves for the indexes of variability (CIPA and standard
deviation of the R-R wave interval) closely resemble each other but
differ from the curve for the effect of atropine on mean R-R interval.
We are uncertain as to the explanation for this. It is conceivable
that, at a submaximal dose, atropine has a more marked effect on the
beat-by-beat modulation of cardiac cycle length than on absolute cycle
length. It is also possible that, during the course of this experiment,
blood pressure, cardiac sympathetic tone, afterload, or other variables
such as circulating neurohormone concentrations were changing in
response to the alterations in cardiac cycle length caused by the
administration of atropine. Because we are uncertain of the explanation
for this observation, we have based our conclusions on the absolute
change in each index caused by full atropinization rather than on the
shape of the dose-response curves.
Disadvantages of the CIPA.
The NeuroScope is very sensitive to galvanic noises from any source,
particularly electromyographic noises, and therefore elaborate
algorithms for the recognition of the QRS complexes are necessary. It
also requires a very-high-resolution digitized ECG signal, which is not
usually provided by medical equipment currently available in the
market. The method depends solely on the characteristics of cardiac
cycles generated by the SA node under the influences of vagal nerve
impulses and, therefore, cannot assess CIPA by using ectopic beats.
Most importantly, the precise relationship between the actual neural
signals traveling in the cardiac vagal nerve to the SA node and the
CIPA has not been defined.
Limitations of the study.
In designing this experiment, we deliberately strove to avoid
obliterating normal reflex behavior of the cardiovascular system, because the aim was to validate CIPA in an intact and freely behaving animal. These dogs were alert and received no drugs except atropine. We
did not measure blood pressure, afterload, or the circulating levels of
norepinephrine. No attempt was made to assess sympathetic nervous
activity in the peripheral vasculature. All these deliberate omissions
mean that although we can speculate as to why the dose-response curve
of the CIPA has the shape that it does, it is difficult to explain that
shape with confidence. Nevertheless, it is clear that this index is
obliterated in all these animals when a sufficient dose of atropine is
administered, and this observation contrasts with the behavior of the
alternative indexes that we have assessed; for that reason we can be
confident that CIPA is a more specific measure of cardiac
parasympathetic tone than these alternative measures.
There is great interest in the measurement of cardiac vagal tone in
clinical practice to facilitate the recognition of cardiac failure and
the identification of patients at risk of early mortality after
myocardial infarction (24, 27, 30, 37). It is also increasingly
recognized that many cardioactive drugs such as the angiotensin-converting enzyme inhibitors and digitalis glycosides affect the autonomic nervous system and that these effects may be
crucial to the overall therapeutic utility of these drugs (26, 31).
Noninvasive real-time monitoring of cardiac vagal tone with use of the
technique reported here is rapidly and easily performed. It promises to
offer an important new method for the evaluation of the cardiovascular
system in humans and animals and is of utility to the physiologist or
physician who wishes to study dynamic autonomic states.
 |
APPENDIX |
Further details of the generation of the CIPA by the
NeuroScope.
The apparatus and methods were developed by P. O. O. Julu and are
described fully in International Patent Application PCT GB97 03202 (19a). Briefly, a high-resolution time domain of the R-R intervals is
integrated using a time constant of 2 s. The output from the integrator
is fed in parallel into a high-pass filter with a cutoff frequency of
0.1 Hz and a low-pass filter of the same cutoff frequency. The output
of the low-pass filter drives a voltage-controlled oscillator (VCO)
with a linear negative gradient; the output of the high-pass filter is
further integrated and then allowed to drive a second VCO with a
positive linear gradient. The outputs of the two VCOs are fed into a
phase detector, which produces voltages proportional to the phase
differences in its inputs.
The system filters out slowly varying or nonvarying heart periods as
follows: a very low nonvarying heart rate, e.g., 30 beats/min (R-R
interval = 2,000 ms), will generate nearly equal outputs, ~0.6 V in
the high- and low-pass filters. This will cause the two VCOs to
generate output pulses at the same frequency, and the output of the
phase detector will be zero, indicating no cardiac parasympathetic
tone. A very high nonvarying heart rate, e.g., 200 beats/min (R-R
interval = 300 ms), if integrated using the time constant of 2 s, will
generate a high-voltage output in the low-pass filter, close to the
maximum of 1 V, and a very-low-voltage output in the high-pass filter,
close to 0 V. Because the low-pass filter drives a VCO with a negative
gradient, the high voltage will cause it to generate low-frequency
pulses that are fed into the phase detector. Likewise, because the
high-pass filter drives a VCO with a positive gradient, the low voltage
will cause it to generate low-frequency pulses similar to those from
the other VCO. The output of the phase detector will be zero,
indicating no cardiac parasympathetic tone. This system is therefore
independent of the heart rate for the detection of cardiac
parasympathetic tone.
Pulse-synchronized phase shifts in the heart periods will generate
high-voltage outputs from the high-pass filter and a varying output
from the low-pass filter. These in turn will generate variable frequencies in the two VCOs. Therefore, the output of the phase detector will be a time-dependent voltage determined by the phase differences in the outputs of the VCOs at the end of each heartbeat to
indicate the detectable effects of cardiac parasympathetic (vagal) tone
on the heart. Pulse-synchronized phase shifts in the heart periods are
independent of respiration. In all, the arrangement is independent of
heart rate and respiration for the detection of cardiac vagal tone.
The CIPA is measured using an arbitrary scale. The parasympathetic
control of the heart measurable by any index can be defined as the
difference in magnitudes of that index before and after the elimination
of all vagal effects on the heart, i.e., the response to full
atropinization (18). Mean basal CIPA in a sample of supine resting
human volunteers was arbitrarily set at 10 units. The units were
derived by dividing the measurable effects of cardiac vagal activity
into 10 equal parts, thus giving a linear scale with an absolute zero
reference point. It is not implied that the CIPA units are linearly
related to the cardiovagal nervous discharges.
 |
ACKNOWLEDGEMENTS |
We are grateful to Profs. Max Murray and David Bennett for
providing the facilities for this study and the nursing staff of Biological Services, University of Glasgow, for able assistance.
 |
FOOTNOTES |
This study was supported by funding from The University of Glasgow
Innovations Fund, Tenovus (Scotland), the Scottish Higher Education
Funding Council Regional Strategic Initiative, and Hoechst UK, Animal
Health Division.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: C. J. L. Little, Animal Health Product
Development, IPC D879, Pfizer Ltd., Ramsgate Rd., Sandwich, Kent CT13
9NJ, UK.
Received 16 March 1998; accepted in final form 30 September 1998.
 |
REFERENCES |
1.
Akselrod, S.
Components of heart rate variability: basic studies.
In: Heart Rate Variability, edited by M. Malik,
and A. J. Camm. New York: Futura, 1995, p. 147-163.
2.
Akselrod, S.,
D. Gordon,
J. B. Madwed,
N. C. Snidman,
D. C. Shannon,
and
R. J. Cohen.
Hemodynamic regulation: investigation by spectral analysis.
Am. J. Physiol.
249 (Heart Circ. Physiol. 18):
H867-H875,
1985[Abstract/Free Full Text].
3.
Angelone, A.,
and
N. A. Coulter.
Respiratory sinus arrhythmia: a frequency-dependent phenomenon.
J. Appl. Physiol.
19:
479-482,
1964[Abstract/Free Full Text].
4.
Bernardi, L.,
S. Leuzzi,
A. Radaelli,
C. Passino,
J. A. Johnston,
and
P. Sleight.
Low-frequency spontaneous fluctuations of R-R interval and blood pressure in conscious humans: a baroreceptor or central phenomenon?
Clin. Sci. (Lond.)
87:
649-654,
1994[Medline].
5.
Bonagura, J. D.,
and
W. W. Muir.
Antiarrhythmic therapy.
In: Essentials of Canine and Feline Electrocardiography (3rd ed.), edited by L. P. Tilley. Philadelphia, PA: Lea & Febiger, 1992, p. 320-364.
6.
Brown, G. L.,
and
J. C. Eccles.
The action of a single vagal volley on the rhythm of the heart beat.
J. Physiol. (Lond.)
82:
211-241,
1934.
7.
Chassaing, C.,
M. Boucher,
C. Breysse,
P. Duchêne-Marullaz,
and
E. Chapuy.
Contribution of vagal blockade to the tachycardia induced by the antimuscarinic agents atropine and pirenzepine.
J. Auton. Pharmacol.
12:
359-368,
1992[Medline].
8.
Daly, M. de B.
Aspects of the integration of the respiratory and cardiovascular systems.
In: Cardiovascular Regulation, edited by D. Jordan,
and J. Marshall. London: Physiological Society/Portland Press, 1995, p. 15-35.
9.
DeBoer, R. W.,
J. M. Karemaker,
and
J. Strackee.
Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model.
Am. J. Physiol.
253 (Heart Circ. Physiol. 22):
H680-H689,
1987[Abstract/Free Full Text].
10.
Eckberg, D. L.
Temporal response patterns of the human sinus node to brief carotid baroreceptor stimuli.
J. Physiol. (Lond.)
258:
769-782,
1976[Abstract/Free Full Text].
11.
Eckberg, D. L.
Human sinus arrhythmia as an index of vagal cardiac outflow.
J. Appl. Physiol.
54:
961-966,
1983[Abstract/Free Full Text].
12.
Fouad, F. M.,
R. C. Tarazi,
C. M. Ferrario,
S. Fighaly,
and
C. Alicandri.
Assessment of parasympathetic control of heart rate by a noninvasive method.
Am. J. Physiol.
246 (Heart Circ. Physiol. 15):
H838-H842,
1984.
13.
Gandevia, S. C.,
D. I. McCloskey,
and
E. K. Potter.
Reflex bradycardia occurring in response to diving, nasopharyngeal stimulation and ocular pressure, and its modification by respiration and swallowing.
J. Physiol. (Lond.)
276:
383-394,
1978[Abstract/Free Full Text].
14.
Hainsworth, R.
The control and physiological importance of heart rate.
In: Heart Rate Variability, edited by M. Malik,
and A. J. Camm. New York: Futura, 1995, p. 3-19.
15.
Halliwill, J. R.,
and
G. E. Billman.
Effect of general anesthesia on cardiac vagal tone.
Am. J. Physiol.
262 (Heart Circ. Physiol. 31):
H1719-H1724,
1992[Abstract/Free Full Text].
16.
Hedman, A. E.,
J. E. K. Hartikainen,
K. U. O. Tahvanainen,
and
M. O. K. Hakumaki.
The high-frequency component of heart rate variability reflects cardiac parasympathetic modulation rather than parasympathetic "tone."
Acta Physiol. Scand.
155:
267-273,
1995[Medline].
17.
Jordan, D.
Central nervous integration of cardiovascular regulation.
In: Cardiovascular Regulation, edited by D. Jordan,
and J. Marshall. London: Physiological Society/Portland Press, 1995, p. 1-14.
18.
Julu, P. O. O.
A linear scale for measuring vagal tone in man.
J. Auton. Pharmacol.
12:
109-115,
1992[Medline].
19.
Julu, P. O. O.
Central action of atropine on cardiovascular reflexes in humans.
J. Cardiovasc. Pharmacol.
20:
332-336,
1992[Medline].
19a.
Julu, P. O. O., and C. Little (Inventors).
University Court of the University of
Glasgow (Assignee). Apparatus and
Method for Measuring Cardiac Vagal Tone. 28 May
1998, Int. Cl. A61B 5/0472. WO 98/22020.
20.
Katona, P. G.,
and
F. Jih.
Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control.
J. Appl. Physiol.
39:
801-805,
1975[Abstract/Free Full Text].
21.
Katona, P. G.,
D. Lipson,
and
P. J. Dauchot.
Opposing central and peripheral effects of atropine on parasympathetic cardiac control.
Am. J. Physiol.
232 (Heart Circ. Physiol. 1):
H146-H151,
1977[Abstract/Free Full Text].
22.
Katona, P. G.,
J. W. Poitras,
G. O. Barnett,
and
B. S. Terry.
Cardiac vagal efferent activity and heart period in the carotid sinus reflex.
Am. J. Physiol.
218:
1030-1037,
1970.
23.
Keele, C. A.,
E. Neil,
and
N. Joels.
The heart rate.
In: Samson Wright's Applied Physiology (13th ed.). Oxford, UK: Oxford University Press, 1982, p. 128-133.
24.
Kleiger, R. E.,
J. P. Miller,
J. T. Bigger, Jr.,
A. J. Moss,
and
the Multicentre Post-Infarction Research Group.
Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.
Am. J. Cardiol.
57:
256-262,
1987.
25.
Kottmeier, C. A.,
and
J. S. Gravenstein.
The parasympathomimetic activity of atropine and atropine methylbromide.
Anesthesiology
29:
1125-1133,
1968[Medline].
26.
Krum, H.,
J. T. Bigger, Jr.,
R. L. Goldsmith,
and
M. Packer.
Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure.
J. Am. Coll. Cardiol.
25:
289-294,
1995[Abstract].
27.
La Rovere, M. T.,
J. T. Bigger, Jr.,
F. I. Marcus,
A. Mortara,
and
P. J. Schwartz for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.
Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction.
Lancet
351:
478-484,
1998[Medline].
28.
Laude, D.,
M. Goldman,
P. Escourrou,
and
J.-L. Elghozi.
Effect of breathing pattern on blood pressure and heart rate oscillations in humans.
Clin. Exp. Pharmacol. Physiol.
20:
619-626,
1993[Medline].
29.
Mokrane, A.,
A. R. Leblanc,
and
R. Nadeau.
Transfer function analysis of vagal control of heart rate during synchronized vagal stimulation.
Am. J. Physiol.
269 (Heart Circ. Physiol. 38):
H1931-H1940,
1995[Abstract/Free Full Text].
30.
Nolan, J.,
A. D. Flapan,
S. Capewell,
T. M. MacDonald,
J. M. M. Neilson,
and
D. J. Ewing.
Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function.
Br. Heart J.
67:
482-485,
1992[Abstract/Free Full Text].
31.
Osterziel, K. J.,
R. Dietz,
W. Schmid,
K. Mikulaschek,
J. Manthey,
and
W. Kübler.
ACE inhibition improves vagal reactivity in patients with heart failure.
Am. Heart J.
120:
1120-1129,
1990[Medline].
32.
Parker, P.,
B. G. Celler,
E. K. Potter,
and
D. I. McCloskey.
Vagal stimulation and cardiac slowing.
J. Auton. Nerv. Syst.
11:
226-231,
1984[Medline].
33.
Pfeifer, M. A.,
D. Cook,
J. Brodsky,
D. Tice,
A. Reenan,
S. Swedine,
J. B. Halter,
and
D. Porte, Jr.
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man.
Diabetes
31:
339-345,
1982[Abstract].
34.
Piepoli, M.,
P. Sleight,
S. Leuzzi,
F. Valle,
G. Spadacini,
C. Passino,
J. Johnston,
and
L. Bernardi.
Origin of respiratory sinus arrhythmia in conscious humans. An important role for arterial carotid baroreceptors.
Circulation
95:
1813-1821,
1997[Abstract/Free Full Text].
35.
Pomeranz, B.,
R. J. B. MacAulay,
M. A. Caudill,
I. Kutz,
D. Adam,
D. Gordon,
K. M. Kilborn,
A. C. Barger,
D. C. Shannon,
R. J. Cohen,
and
H. Benson.
Assessment of autonomic function in humans by heart rate spectral analysis.
Am. J. Physiol.
248 (Heart Circ. Physiol. 17):
H151-H153,
1985[Abstract/Free Full Text].
36.
Rimoldi, O.,
S. Pierini,
A. Ferrari,
S. Cerutti,
M. Pagani,
and
A. Mallini.
Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs.
Am. J. Physiol.
258 (Heart Circ. Physiol. 27):
H967-H976,
1990[Abstract/Free Full Text].
37.
Saul, J. P.,
Y. Arai,
R. D. Berger,
L. S. Lilly,
W. S. Colucci,
and
R. J. Cohen.
Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis.
Am. J. Cardiol.
61:
1292-1299,
1988[Medline].
38.
Sleight, P.,
M. T. La Rovere,
A. Mortara,
G. Pinna,
R. Maestri,
S. Leuzzi,
B. Bianchini,
L. Tavazzi,
and
L. Bernardi.
Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain?
Clin. Sci. (Lond.)
88:
103-109,
1995[Medline].
39.
Swenne, C. A., M. Bootsma, B. W. Hyndman, J. Voogd, and A. V. G. Bruschke. Heart rate variability,
baroreflex sensitivity, and cardiac vagal tone. Clin.
Sci. (Lond.) 91, Suppl.: 113-115, 1996.
40.
Vicenzi, M. N.,
H. J. Woehlck,
M. Boban,
B. McCallum,
J. L. Atlee,
and
Z. J. Bosnjak.
Muscarinic and ganglionic blocking properties of atropine compounds in vivo and in vitro: time dependence and heart rate effects.
Can. J. Physiol. Pharmacol.
73:
483-490,
1995[Medline].
Am J Physiol Heart Circ Physiol 276(2):H758-H765
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society